[go: up one dir, main page]

BRPI0804518A2 - método de controle de uma população de cães - Google Patents

método de controle de uma população de cães Download PDF

Info

Publication number
BRPI0804518A2
BRPI0804518A2 BRPI0804518-6A BRPI0804518A BRPI0804518A2 BR PI0804518 A2 BRPI0804518 A2 BR PI0804518A2 BR PI0804518 A BRPI0804518 A BR PI0804518A BR PI0804518 A2 BRPI0804518 A2 BR PI0804518A2
Authority
BR
Brazil
Prior art keywords
dog
dogs
population
controlling
freely
Prior art date
Application number
BRPI0804518-6A
Other languages
English (en)
Inventor
Wang Min
Original Assignee
Fahim Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fahim Technology Inc filed Critical Fahim Technology Inc
Publication of BRPI0804518A2 publication Critical patent/BRPI0804518A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/315Zinc compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Feed For Specific Animals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

MéTODO DE CONTROLE DE UMA POPULAçãO DE CãES. Trata-se de um método de controle de uma população de cães com a composição química para o uso no controle da população de cães machos sexualmente maduros que perambulam livremente. O esterilizador químico é injetado de uma maneira que a aparência e as características sexuais masculinas secundárias do cão sejam preservadas de maneira tal que o cão mantenha a sua posição na hierarquia dos cães que perambulam livremente enquanto não contribui com o número dos filhotes de cães produzidos. Uma redução ao número de cães que perambulam livremente reduz o número de vítimas humanas da raiva adquirida por mordida de cão. Devido ao fato que a aparência e a natureza do cão esterilizado ficam substancialmente inalteradas, a composição química é aceitável para a comunidade humana que o cão habita.
BRPI0804518-6A 2007-09-28 2008-09-26 método de controle de uma população de cães BRPI0804518A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/863,758 US20090088471A1 (en) 2007-09-28 2007-09-28 Chemical sterilant for adult male dog population control with concomitant reduction in human dog-bite acquired rabies
PCT/US2008/011187 WO2009045337A1 (en) 2007-09-28 2008-09-26 Chemical sterilant for adult male dog population control, comprising a mineral gluconate and an amino acid

Publications (1)

Publication Number Publication Date
BRPI0804518A2 true BRPI0804518A2 (pt) 2011-08-30

Family

ID=40089865

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0804518-6A BRPI0804518A2 (pt) 2007-09-28 2008-09-26 método de controle de uma população de cães

Country Status (12)

Country Link
US (1) US20090088471A1 (pt)
EP (1) EP2192897A1 (pt)
CN (1) CN101888838A (pt)
AR (1) AR068581A1 (pt)
BR (1) BRPI0804518A2 (pt)
CL (1) CL2008002909A1 (pt)
CO (1) CO6270316A2 (pt)
MX (1) MX2010003474A (pt)
PA (1) PA8797601A1 (pt)
PE (1) PE20091031A1 (pt)
RU (1) RU2455000C2 (pt)
WO (1) WO2009045337A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4201475A1 (en) 2011-01-03 2023-06-28 The Regents of the University of California High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury
WO2013071307A1 (en) 2011-11-11 2013-05-16 Edgerton Victor Reggie Non invasive neuromodulation device for enabling recovery of motor, sensory, autonomic, sexual, vasomotor and cognitive function
ES2902651T3 (es) * 2012-08-23 2022-03-29 Senestech Inc Reducción de la capacidad reproductiva de mamíferos
WO2014144785A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion
US20140271716A1 (en) 2013-03-15 2014-09-18 Ark Sciences, Inc. Intra-testicular Injection of Immunogens
EP3049148B1 (en) 2013-09-27 2020-05-20 The Regents Of The University Of California Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects
US11235154B2 (en) 2017-02-17 2022-02-01 The University Of British Columbia Apparatus and methods for maintaining physiological functions
US12434068B2 (en) 2017-05-23 2025-10-07 The Regents Of The University Of California Accessing spinal networks to address sexual dysfunction
DE20168827T1 (de) 2017-06-30 2021-01-21 Gtx Medical B.V. System zur neuromodulierung
US12357828B2 (en) 2017-12-05 2025-07-15 Ecole Polytechnique Federale De Lausanne (Epfl) System for planning and/or providing neuromodulation
WO2019110400A1 (en) 2017-12-05 2019-06-13 Ecole Polytechnique Federale De Lausanne (Epfl) A system for planning and/or providing neuromodulation
JP2021534877A (ja) 2018-08-23 2021-12-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California 神経根麻痺、馬尾症候群、及び上肢機能の回復のための非侵襲性脊髄刺激
EP3653256B1 (en) 2018-11-13 2022-03-30 ONWARD Medical N.V. Control system for movement reconstruction and/or restoration for a patient
EP3695878B1 (en) 2019-02-12 2023-04-19 ONWARD Medical N.V. A system for neuromodulation
EP3827871A1 (en) 2019-11-27 2021-06-02 ONWARD Medical B.V. Neuromodulation system
EP3827875B1 (en) 2019-11-27 2023-07-05 ONWARD Medical N.V. Neuromodulation system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156427A (en) * 1976-01-23 1979-05-29 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes
US4339438A (en) * 1976-01-23 1982-07-13 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes
US4937234A (en) * 1988-08-10 1990-06-26 Fahim Mostafa S Minerals in bioavailable form
US5070080A (en) * 1988-08-10 1991-12-03 Fahim Mostafa S Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form
US5372822A (en) * 1994-03-07 1994-12-13 Fahim; Mostafa S. Chemical castration
US7125385B1 (en) * 2003-04-14 2006-10-24 Technology Transfer, Inc. Instrument for determining intratesticular dose and method for determining a dose
US7276535B1 (en) * 2003-04-14 2007-10-02 Technology Transfer, Inc. Intratesticular injection of chemical sterilant

Also Published As

Publication number Publication date
CO6270316A2 (es) 2011-04-20
WO2009045337A1 (en) 2009-04-09
CN101888838A (zh) 2010-11-17
PA8797601A1 (es) 2010-05-26
PE20091031A1 (es) 2009-08-19
RU2455000C2 (ru) 2012-07-10
MX2010003474A (es) 2010-08-04
CL2008002909A1 (es) 2009-09-04
AR068581A1 (es) 2009-11-18
US20090088471A1 (en) 2009-04-02
RU2010116777A (ru) 2011-11-10
EP2192897A1 (en) 2010-06-09

Similar Documents

Publication Publication Date Title
BRPI0804518A2 (pt) método de controle de uma população de cães
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
BRPI0416881A (pt) método para reduzir odor excrementos de um animal doméstico.
UY26269A1 (es) Formulación de sal común y moxifloxacina
BRPI0925036B8 (pt) uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele
ECSP056138A (es) Dihidroquinazolinas sustituidas
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
TW200505425A (en) Compositions and method for treating infection in cattle and swine
UY30762A1 (es) Sal fumarato de (alfa s, beta r)-6-bromo-alfa-[2(dimetilamino) etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
WO2009055799A3 (en) Compositions and methods for treatment of diseases of the foot of an animal
AR043824A1 (es) Composiciones y metodo para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
ES2194535T3 (es) 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contien y su uso como agente parala lucha contra organismos dañinos.
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
GT200400220A (es) Productos para las axilas con componente superabsorbente.
CL2004000979A1 (es) Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida.
BRPI0408499A (pt) solução aquosa estável de um fungicida de polieno
BRPI0413413A (pt) feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada
SV2006002290A (es) Nonadepsipeptidos acilados ii ref. bhc041327-sv
BRPI0418764A (pt) uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável
CL2009000987A1 (es) Composición de alimentación que comprende peptidoglicano y nucleotidos; y su uso para la profilaxis y/o tratamiento de enfermedades infecciosas en animales.
BRPI0907224A2 (pt) formulações narcórticas em emulsão para tratamento de dor cirúrgica
BRPI0506630A (pt) composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada
BR0210063A (pt) Composição estável e uso da mesma

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2325 DE 28-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.